169 related articles for article (PubMed ID: 18334836)
1. Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight.
Danese S
Pathobiology; 2008; 75(1):22-4. PubMed ID: 18334836
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.
Punekar S; Zak S; Kalter VG; Dobransky L; Punekar I; Lawler JW; Gutierrez LS
Pathobiology; 2008; 75(1):9-21. PubMed ID: 18334835
[TBL] [Abstract][Full Text] [Related]
3. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
Chidlow JH; Shukla D; Grisham MB; Kevil CG
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease.
Danese S; Scaldaferri F; Vetrano S; Stefanelli T; Graziani C; Repici A; Ricci R; Straface G; Sgambato A; Malesci A; Fiocchi C; Rutella S
Gut; 2007 Sep; 56(9):1248-56. PubMed ID: 17317789
[TBL] [Abstract][Full Text] [Related]
6. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
Hatoum OA; Heidemann J; Binion DG
Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
[TBL] [Abstract][Full Text] [Related]
7. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
Danese S
Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
[TBL] [Abstract][Full Text] [Related]
9. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease.
Binion DG; Rafiee P
Gastroenterology; 2009 Feb; 136(2):400-3. PubMed ID: 19111728
[No Abstract] [Full Text] [Related]
10. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of lymphatics in inflammatory bowel disease.
Alexander JS; Chaitanya GV; Grisham MB; Boktor M
Ann N Y Acad Sci; 2010 Oct; 1207 Suppl 1():E75-85. PubMed ID: 20961310
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in inflammatory bowel disease.
Pousa ID; Maté J; Gisbert JP
Eur J Clin Invest; 2008 Feb; 38(2):73-81. PubMed ID: 18226040
[TBL] [Abstract][Full Text] [Related]
14. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
Thatch KA; Mendelson KG; Haber MM; Schwartz MZ
J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260
[TBL] [Abstract][Full Text] [Related]
15. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
16. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
17. The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation.
Lust M; Vulcano M; Danese S
Trends Mol Med; 2008 Jun; 14(6):237-44. PubMed ID: 18457995
[TBL] [Abstract][Full Text] [Related]
18. Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis.
Halin C; Detmar M
Methods Enzymol; 2008; 445():1-25. PubMed ID: 19022053
[TBL] [Abstract][Full Text] [Related]
19. Tracking adult neovascularization during ischemia and inflammation using Vegfr2-LacZ reporter mice.
Heidenreich R; Murayama T; Silver M; Essl C; Asahara T; Rocken M; Breier G
J Vasc Res; 2008; 45(5):437-44. PubMed ID: 18418002
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of inflammatory bowel disease.
Byrne FR; Viney JL
Curr Opin Drug Discov Devel; 2006 Mar; 9(2):207-17. PubMed ID: 16566291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
